InMed Pharmaceuticals Inc. (INM) Reports Q1 Loss of $2.17
Tweet
Share
E-mailGet Alerts INM Hot Sheet
Join SI Premium – FREE
InMed Pharmaceuticals Inc. (NASDAQ: INM) reported Q1 EPS of ($2.17). Revenue for the quarter came in at $1.26 million.
For earnings history and earnings-related data on InMed Pharmaceuticals Inc. (INM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SLM (SLM) Misses Q2 EPS by 16c; offers guidance
- First Bank (FRBA) Reports In-Line Q2 EPS
- Midland States Bancorp, Inc. (MSBI) Tops Q2 EPS by 4c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
